Neutrophil mediated immunity

pathway activity — cross-omics
GO:0002446Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Neutrophil mediated immunity pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MEFV, BCL2A1, and FPR2, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Neutrophil mediated immunity activity versus MEFV in LSCC (Pearson r = 0.09).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCMEFV →+0.672+0.226<.001<.00138
COADBCL2A1 →+1.135+0.135.007.00738
LSCCFPR2 →+1.172+0.347<.001<.00138
COADFPR1 →+1.057+0.139.004.00538
COADSLC11A1 →+1.110+0.172<.001<.00138
GBMFGR →+0.692+0.188<.001<.00138
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002446 vs MEFV — LSCC

Per-sample scatter of Neutrophil mediated immunity activity vs MEFV in LSCC.

Explore this scatter interactively →

Exploration